171 related articles for article (PubMed ID: 14565514)
21. Topotecan: a review of its efficacy in small cell lung cancer.
Ormrod D; Spencer CM
Drugs; 1999 Sep; 58(3):533-51. PubMed ID: 10493279
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy as treatment of primary and recurrent small cell lung cancer.
Schuette W
Lung Cancer; 2001 Sep; 33 Suppl 1():S99-107. PubMed ID: 11576714
[TBL] [Abstract][Full Text] [Related]
23. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer.
Laurie SA; Logan D; Markman BR; Mackay JA; Evans WK;
Lung Cancer; 2004 Feb; 43(2):223-40. PubMed ID: 14739044
[TBL] [Abstract][Full Text] [Related]
24. Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Gatzemeier U; von Pawel J; Laumen R; Hossfeld DK; Neuhauss R; Reck M; Lenaz L
Oncology; 1992; 49 Suppl 1():25-33. PubMed ID: 1323809
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.
Bunn PA; Greco FA; Einhorn L
Semin Oncol; 1986 Sep; 13(3 Suppl 3):45-53. PubMed ID: 3020700
[TBL] [Abstract][Full Text] [Related]
26. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
[TBL] [Abstract][Full Text] [Related]
27. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
28. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
29. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
[TBL] [Abstract][Full Text] [Related]
30. The role of ifosfamide in small cell lung cancer.
Loehrer PJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
[TBL] [Abstract][Full Text] [Related]
31. [Recent trends of chemotherapy in small cell lung cancer: a slow but steady progress].
Ohnoshi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2522-30. PubMed ID: 2549879
[TBL] [Abstract][Full Text] [Related]
32. [Evidence based chemotherapy for lung cancer].
Watanabe H; Saijo N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
[TBL] [Abstract][Full Text] [Related]
33. Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
Thatcher N; Qian W; Clark PI; Hopwood P; Sambrook RJ; Owens R; Stephens RJ; Girling DJ
J Clin Oncol; 2005 Nov; 23(33):8371-9. PubMed ID: 16293867
[TBL] [Abstract][Full Text] [Related]
34. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.
Johnson DH; Bass D; Einhorn LH; Crawford J; Perez CA; Bartolucci A; Omura GA; Greco FA
J Clin Oncol; 1993 Jul; 11(7):1223-9. PubMed ID: 8391064
[TBL] [Abstract][Full Text] [Related]
35. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
Murray N; Shah A; Brown E; Kostashuk E; Laukkanen E; Goldie J; Band P; Van den Hoek J; Murphy K; Sparling T
Semin Oncol; 1986 Sep; 13(3 Suppl 3):24-30. PubMed ID: 3020695
[TBL] [Abstract][Full Text] [Related]
36. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
[TBL] [Abstract][Full Text] [Related]
37. Ifosfamide in small cell lung cancer.
Einhorn LH
Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Lorigan P; Lee SM; Betticher D; Woodhead M; Weir D; Hanley S; Hardy C; Thatcher N
Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
[TBL] [Abstract][Full Text] [Related]
40. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
